000 01231 a2200337 4500
005 20250517130453.0
264 0 _c20170119
008 201701s 0 0 eng d
022 _a1879-0461
024 7 _a10.1016/j.critrevonc.2016.10.008
_2doi
040 _aNLM
_beng
_cNLM
100 1 _avan Marcke, Cedric
245 0 0 _aRoutine use of gene panel testing in hereditary breast cancer should be performed with caution.
_h[electronic resource]
260 _bCritical reviews in oncology/hematology
_cDec 2016
300 _a33-39 p.
_bdigital
500 _aPublication Type: Journal Article; Review
650 0 4 _aBRCA1 Protein
_xgenetics
650 0 4 _aBRCA2 Protein
_xgenetics
650 0 4 _aBreast Neoplasms
_xgenetics
650 0 4 _aGenetic Predisposition to Disease
650 0 4 _aGerm-Line Mutation
650 0 4 _aHigh-Throughput Nucleotide Sequencing
650 0 4 _aHumans
650 0 4 _aRisk Factors
700 1 _aDe Leener, Anne
700 1 _aBerlière, Martine
700 1 _aVikkula, Miikka
700 1 _aDuhoux, Francois P
773 0 _tCritical reviews in oncology/hematology
_gvol. 108
_gp. 33-39
856 4 0 _uhttps://doi.org/10.1016/j.critrevonc.2016.10.008
_zAvailable from publisher's website
999 _c26678635
_d26678635